MONROE TOWNSHIP, N.J., Nov. 23, 2018 /PRNewswire/ -- An estimated 400 million medical imaging procedures are performed each year in the United States.1 To demonstrate the company's commitment to the challenges faced by the healthcare professionals involved in those procedures and the patients they serve, Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, reaffirms the company's vision on addressing the diagnostic imaging needs of today and tomorrow.
"As the imaging industry evolves with an emphasis on safe, efficient, cost effective, and personalized patient care, Bracco is at the forefront of that change, constantly advancing our products, services and expertise to offer ever increasing added value to all of our customers today and tomorrow," said Vittorio Puppo, President and CEO of Bracco Diagnostics Inc. "The advances Bracco has made with our product portfolio continuously demonstrate our commitment to address the needs of healthcare providers."
Bracco will highlight its full scope of offerings and advancements with its diagnostic imaging services and solutions portfolio at the 2018 RSNA Annual Meeting (South Hall Level 3, Booth #1911), including Bracco's:
Ad Statistics
Times Displayed: 8061
Times Visited: 26 Brand-New FDA-cleared Advanced Ultrasound Medical Device available for sale or lease to Wound Care Centers or any other Medical Facilities.The Arobella 1000D is designed for non-contact or debridement ultrasound wound healing therapy, or any other wounds
Focus on patient care and the power of choice, giving customers the ability to assess each patient's personal needs and decide upon the best contrast media option for their patients, whether the contrast is for an MRI, X-ray/CT, Ultrasound or Nuclear Medicine examination.
Commitment to smart solutions and innovative technologies to improve workflow, optimize image quality, and maximize efficiency.
Dedication and passion for funding education for the medical community with comprehensive, convenient programs tailored to address today's health care challenges, including interactive carousels for RSNA attendees to explore Bracco offerings and clinical breakthroughs to improve outcomes.
Puppo added, "At Bracco, we take pride in what we do, and our shared vision is evident in every innovation, research opportunity and action we take in our relentless pursuit of better serving our customers, and ultimately to help improve patients' lives."
Visit the Bracco booth (#1911) to learn more.
About Bracco Imaging
Bracco Imaging S.p.A., part of the Bracco Group, is one of the world's leading companies in the diagnostic imaging business. Headquartered in Milan, Italy, Bracco Imaging develops, manufactures and markets diagnostic imaging agents and solutions that meet medical needs.
